NAACCR 2026 Virtual Conference
True North: Aligning Data, Discovery, and Impact
Join us for the NAACCR 2026 virtual conference June 23-25, 2026, hosted by the Manitoba Cancer Registry, CancerCare Manitoba! While it is unfortunate that we won’t be gathering
in-person in Winnipeg this year, we look forward to providing an excellent educational program with plenty of opportunities to exchange ideas and network with colleagues. The 2026 conference will provide attendees with the opportunity to learn from national experts in cancer surveillance, cancer registry operations, and cancer research. Sessions will explore the new era in cancer surveillance from multiple perspectives in North America.
The preliminary agenda for the NAACCR 2026 conference is now available! While this is a virtual meeting, there is A LOT to get excited about. We'll be featuring a wide range of cancer registry and surveillance topics, local and global experts, world-class speakers, and moderated breakout sessions with opportunities for you to engage with colleagues and partners from across the entire North American cancer data community. Specific areas of focus will include cancer surveillance, cancer registry operations, analytical methods, research, artificial intelligence (AI) and innovative approaches to using data for cancer control. We look forward to seeing you online this June as we celebrate the present and future of our community and the critical work we do!
Registration for the 2026 virtual conference is now open and will close June 21, 2026 at 11:59 ET. If you have any questions about registration contact questions2us@naaccr.org.
*Contact the NAACCR office for Retired Individual or Student registration link: questions2us@naaccr.org
The Call for Abstracts is closed. Authors of submitted abstracts will be contacted in coming weeks. All submitters whose abstracts are accepted must be available June 23-25, 2026, to present on-line at a scheduled time to be determined in the Spring of 2026.
This program is supported in part by NCI Conference Grant 1R13CA301749, NCI Contract Number 75N91021D00018, and CDC Cooperative Agreement Number 5NU58DP007575. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute or the Centers for Disease Control and Prevention. Without their support, this scientific conference would not be possible.